Adma Biologics reported $141.37M in Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Adma Biologics ADMA:US USD 141.37M 1.56M
Agile Therapeutics AGRX:US USD 1.32M 11.31M
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Biocryst Pharmaceuticals BCRX:US USD 713.65M 91.47M
Novavax NVAX:US USD 438.09M 10.34M
Omeros OMER:US USD 439.82M 125.46M
Takeda 4502:JP JPY 4.74T 134.39B